Financial statements Amgen Biotechnologia

Balance sheet of Amgen Biotechnologia

Company age:
Age:
14 y. 2 m. 8 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of AMGEN BIOTECHNOLOGIA

Year
2018
2019
2020
2021
2022
2023
Total assets 26 433 045,61 20 087 718,63 25 382 019,54 15 794 100,76 19 231 397,90 21 271 174,98
A. Fixed assets - - - - - 1 868 664,70
B. Current assets - - - - - 19 402 510,28
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 26 433 045,61 20 087 718,63 25 382 019,54 15 794 100,76 19 231 397,90 21 271 174,98
A. Equity - - - - - 12 673 866,97
B. Liabilities and provisions for liabilities - - - - - 8 597 308,01
I. Long-term liabilities - - - - - -
II. Short-term liabilities - - - - - 2 073 866,59
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.